This book is the first authoritative medical text that considers the unique cultural backgrounds of Hispanic populations in a straightforward yet sensitive way, all while building a framework for practical psychiatric assessment and treatment plans.
As the only book to consider the unique challenges facing Hispanic mental healthcare, this book is at the forefront of a serious issue that has gone unchallenged for too long.
The text is written by two expert psychiatrists with an established history of leadership in this space. Chapters carefully and meticulously establish the issues of access to care in Latinx communities before addressing the unique needs of these patients in the context of common psychiatric disorders. Each disorder includes clinical cases for a reader-friendly approach to the challenges that develop effective assessment and treatment plans.
Mental Health for Hispanic Communities is a concise yet comprehensive reference invaluable to all clinicians, students, and other medical professionals seeking to work with this population effectively.
About the Author: Ruby C. Castilla-Puentes, MD, FAPA, DrPH, MBA
Director, Clinical Research Neuroscience Janssen, R&D
Senior Leadership Team Member for Medical Strategies -Hispanic Organization for Leadership and Achievement (HOLA) & Mental Health Diplomats at Johnson & Johnson
President and Founder of WARMI (woman in Quechua/Aymara) Mental Health- United for Women's Mental Health
President of the American Society of Hispanic Psychiatry (ASHP) 2020-2022
Preceptor, Community-Based Projects, Dornsife School of Public Health, Drexel University, Center for Public Health Practice
530 S 2nd St #743
Philadelphia, PA 19147
Tatiana Falcone, MD, FAPA
Child and Adolescent Psychiatrist
Assistant Professor of Medicine
Lerner College of Medicine
Cleveland Clinic
Dr. Ruby Castilla-Puentes currently works at the Neuroscience Research, Johnson & Johnson. Ruby does research in Psychiatry, Neurology, Epidemiology and Emergency Medicine. Ruby's current projects include: BACE inhibitors, orexins trials and other Alzheimer's ans Depression's development programs. Ruby's work includes leading teams to develop and implement tools and technologies to optimize novel medication development for neuropsychiatric conditions. Her most recent project includes the Use of Artificial Inteligence to identify barriers in treatment for depression. Ruby serves in numerous boards of non-profit organizations focused on mental health needs for Women and Undeserved Population. Ruby served as President of the American Society of Hispanic Psychiatry during the period 2020-2022.
